285 related articles for article (PubMed ID: 28549891)
1. Synthesis and pharmacological evaluation of novel chromone derivatives as balanced multifunctional agents against Alzheimer's disease.
Li F; Wu JJ; Wang J; Yang XL; Cai P; Liu QH; Kong LY; Wang XB
Bioorg Med Chem; 2017 Jul; 25(14):3815-3826. PubMed ID: 28549891
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional coumarin derivatives: monoamine oxidase B (MAO-B) inhibition, anti-β-amyloid (Aβ) aggregation and metal chelation properties against Alzheimer's disease.
Huang M; Xie SS; Jiang N; Lan JS; Kong LY; Wang XB
Bioorg Med Chem Lett; 2015 Feb; 25(3):508-13. PubMed ID: 25542589
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of 2-acetyl-5-O-(amino-alkyl)phenol derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Wang H; Wang H; Ma Q; Han X; Ye M; Yu L; Liu W
Bioorg Med Chem Lett; 2017 Nov; 27(22):5046-5052. PubMed ID: 29033233
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of salicyladimine derivatives as multitarget-directed ligands against Alzheimer's disease.
Yang HL; Cai P; Liu QH; Yang XL; Fang SQ; Tang YW; Wang C; Wang XB; Kong LY
Bioorg Med Chem; 2017 Nov; 25(21):5917-5928. PubMed ID: 28988627
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of selegiline derivatives as monoamine oxidase inhibitor, antioxidant and metal chelator against Alzheimer's disease.
Xie S; Chen J; Li X; Su T; Wang Y; Wang Z; Huang L; Li X
Bioorg Med Chem; 2015 Jul; 23(13):3722-9. PubMed ID: 25934229
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of novel dimethylamino chalcone-O-alkylamines derivatives as potential multifunctional agents against Alzheimer's disease.
Sang Z; Song Q; Cao Z; Deng Y; Tan Z; Zhang L
Eur J Med Chem; 2021 Apr; 216():113310. PubMed ID: 33667847
[TBL] [Abstract][Full Text] [Related]
7. Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties.
Cai P; Fang SQ; Yang XL; Wu JJ; Liu QH; Hong H; Wang XB; Kong LY
ACS Chem Neurosci; 2017 Nov; 8(11):2496-2511. PubMed ID: 28806057
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Tan Z
Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
Xu R; Xiao G; Li Y; Liu H; Song Q; Zhang X; Yang Z; Zheng Y; Tan Z; Deng Y
Bioorg Med Chem; 2018 May; 26(8):1885-1895. PubMed ID: 29500132
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease.
Xie SS; Liu J; Tang C; Pang C; Li Q; Qin Y; Nong X; Zhang Z; Guo J; Cheng M; Tang W; Liang N; Jiang N
Eur J Med Chem; 2020 Sep; 202():112475. PubMed ID: 32652406
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of phthalimide-alkylamine derivatives as balanced multifunctional cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer's disease.
Sang Z; Wang K; Wang H; Yu L; Wang H; Ma Q; Ye M; Han X; Liu W
Bioorg Med Chem Lett; 2017 Nov; 27(22):5053-5059. PubMed ID: 29033232
[TBL] [Abstract][Full Text] [Related]
12. DL-3-n-butylphthalide-Edaravone hybrids as novel dual inhibitors of amyloid-β aggregation and monoamine oxidases with high antioxidant potency for Alzheimer's therapy.
Qiang X; Li Y; Yang X; Luo L; Xu R; Zheng Y; Cao Z; Tan Z; Deng Y
Bioorg Med Chem Lett; 2017 Feb; 27(4):718-722. PubMed ID: 28131710
[TBL] [Abstract][Full Text] [Related]
13. Multitarget-directed benzylideneindanone derivatives: anti-β-amyloid (Aβ) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease.
Huang L; Lu C; Sun Y; Mao F; Luo Z; Su T; Jiang H; Shan W; Li X
J Med Chem; 2012 Oct; 55(19):8483-92. PubMed ID: 22978824
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of 4'-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer's disease treatment.
Cao Z; Yang J; Xu R; Song Q; Zhang X; Liu H; Qiang X; Li Y; Tan Z; Deng Y
Bioorg Med Chem; 2018 Mar; 26(5):1102-1115. PubMed ID: 29409707
[TBL] [Abstract][Full Text] [Related]
15. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities.
Jalili-Baleh L; Nadri H; Forootanfar H; Küçükkılınç TT; Ayazgök B; Sharifzadeh M; Rahimifard M; Baeeri M; Abdollahi M; Foroumadi A; Khoobi M
Daru; 2021 Jun; 29(1):23-38. PubMed ID: 33420969
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 4-hydroxyl aurone derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Li Y; Qiang X; Luo L; Li Y; Xiao G; Tan Z; Deng Y
Bioorg Med Chem; 2016 May; 24(10):2342-51. PubMed ID: 27079124
[TBL] [Abstract][Full Text] [Related]
17. Novel 8-hydroxyquinoline derivatives targeting β-amyloid aggregation, metal chelation and oxidative stress against Alzheimer's disease.
Yang X; Cai P; Liu Q; Wu J; Yin Y; Wang X; Kong L
Bioorg Med Chem; 2018 Jul; 26(12):3191-3201. PubMed ID: 29729985
[TBL] [Abstract][Full Text] [Related]
18. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease.
Zhang X; Song Q; Cao Z; Li Y; Tian C; Yang Z; Zhang H; Deng Y
Bioorg Chem; 2019 Jun; 87():395-408. PubMed ID: 30921741
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of 4'-aminochalcone-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Xiao G; Li Y; Qiang X; Xu R; Zheng Y; Cao Z; Luo L; Yang X; Sang Z; Su F; Deng Y
Bioorg Med Chem; 2017 Feb; 25(3):1030-1041. PubMed ID: 28011206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
